Publication: In vitro drug sensitivity testing in Plasmodium vivax
item.page.dc.date.issued
2008-10-01
item.page.dc.type
item.page.dc.identifier.issn
00435325
item.page.dc.identifier.doi
item.page.dc.identifier.other
2-s2.0-57849110633
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Wiener Klinische Wochenschrift. Vol.120, No.SUPPL. 4 (2008), 30-33
punsarn.item.page.citation
Walther H. Wernsdorfer, Oumaporn Tasanor, Gunther Wernsdorfer In vitro drug sensitivity testing in Plasmodium vivax. Wiener Klinische Wochenschrift. Vol.120, No.SUPPL. 4 (2008), 30-33. doi:10.1007/s00508-008-1030-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/19516
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
In vitro drug sensitivity testing in Plasmodium vivax
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
The possibility of short-term in vitro cultivation, i.e. growth of asexual erythrocytic stages up to the stage of mature schizonts, permits in principle the development of drug sensitivity tests also for Plasmodium vivax. In the absence of a sequestration of erythrocytes carrying the advanced stages of schizogony, asexual parasites of all stages may be seen in the peripheral blood of patients infected with P. vivax. This precludes schizont maturation tests since schizont development will be unduly influenced by the number of advanced trophozoites. A test system reflecting the age composition of the parasite population and its progression without and under the influence of inhibitors was found to yield precise results also in the higher IC ranges. The population-based test procedure would also permit the identification of any stage-specific impact of antimalarial agents. © 2008 Springer-Verlag.